Compare TTK HEALTHCARE with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ASTRAZENECA PHARMA TTK HEALTHCARE/
ASTRAZENECA PHARMA
 
P/E (TTM) x 12.6 126.2 10.0% View Chart
P/BV x 1.8 38.6 4.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 TTK HEALTHCARE   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
ASTRAZENECA PHARMA
Mar-18
TTK HEALTHCARE/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2151,278 95.1%   
Low Rs610883 69.1%   
Sales per share (Unadj.) Rs444.4228.4 194.6%  
Earnings per share (Unadj.) Rs17.210.4 166.4%  
Cash flow per share (Unadj.) Rs27.616.3 169.9%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.998.8 180.2%  
Shares outstanding (eoy) m14.1325.00 56.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.14.7 43.4%   
Avg P/E ratio x52.9104.2 50.8%  
P/CF ratio (eoy) x33.066.4 49.7%  
Price / Book Value ratio x5.110.9 46.9%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,89427,008 47.7%   
No. of employees `0002.31.4 170.5%   
Total wages/salary Rs m1,3071,535 85.1%   
Avg. sales/employee Rs Th2,715.74,210.9 64.5%   
Avg. wages/employee Rs Th565.31,132.2 49.9%   
Avg. net profit/employee Rs Th105.4191.1 55.2%   
INCOME DATA
Net Sales Rs m6,2795,710 110.0%  
Other income Rs m78123 63.3%   
Total revenues Rs m6,3565,833 109.0%   
Gross profit Rs m496463 107.1%  
Depreciation Rs m147147 99.5%   
Interest Rs m340-   
Profit before tax Rs m393438 89.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m149179 83.2%   
Profit after tax Rs m244259 94.1%  
Gross profit margin %7.98.1 97.4%  
Effective tax rate %37.940.8 92.9%   
Net profit margin %3.94.5 85.5%  
BALANCE SHEET DATA
Current assets Rs m2,7173,209 84.7%   
Current liabilities Rs m1,5712,070 75.9%   
Net working cap to sales %18.320.0 91.5%  
Current ratio x1.71.6 111.5%  
Inventory Days Days3272 44.5%  
Debtors Days Days4735 133.6%  
Net fixed assets Rs m991790 125.4%   
Share capital Rs m14150 282.6%   
"Free" reserves Rs m2,3732,419 98.1%   
Net worth Rs m2,5142,469 101.8%   
Long term debt Rs m30-   
Total assets Rs m4,1584,605 90.3%  
Interest coverage x12.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.51.2 121.8%   
Return on assets %6.75.6 118.6%  
Return on equity %9.710.5 92.4%  
Return on capital %16.917.7 95.5%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m225300 75.2%   
Fx outflow Rs m712,015 3.5%   
Net fx Rs m154-1,715 -9.0%   
CASH FLOW
From Operations Rs m17388 196.9%  
From Investments Rs m97-94 -103.1%  
From Financial Activity Rs m-307NA-  
Net Cashflow Rs m-38-6 661.4%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 0.3 1,233.3%  
FIIs % 5.2 15.7 33.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 9.1 283.5%  
Shareholders   12,723 12,856 99.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC  ALKEM LABORATORIES  ELDER PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 6, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS